In this study, we showed that XO is overexpressed in the inflamed mucosa of IBD patients, contributing to inflammation, at least in part, by NLRP3 inflammasome activation and expression of the proinflammatory cytokines IL1beta and IL18. The gene discussed is NLRP3; the disease is inflammatory bowel disease.